Diltiazem Hydrochloride Injection, Solution
Product Images NDC 25021-319

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Diltiazem Hydrochloride (NDC 25021-319). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Sagent Pharmaceuticals, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Structural Formula (Dil0b 0000 01)

FDA Label Image

Package Label – Principal Display Panel – Vial Label (Dil0b 0000 02)

FDA Label Image

Package Label – Principal Display Panel – Vial Label (Dil0b 0000 03)

FDA Label Image

Package Label – Principal Display Panel – Vial Label (Dil0b 0000 04)

Package Label – Principal Display Panel – Vial Label (Dil0b 0000 04)
This text is detailing a pharmaceutical product labeled with information such as product name, manufacturer, country of origin, dosage, and content details. The product is made for SAGENT Pharmaceuticals in India. It is a 25 mL Single-Dose Vial with a specific code number provided. The text also mentions the copyright of ©2023 Sagent Pharmaceuticals. The product information includes some characters not recognizable in English.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.